Valuation: CHF Solutions

Market Cap 292K 256K 239K 219K 412K 27.97M 417K 2.84M 1.11M 13.81M 1.1M 1.07M 47.74M P/E 2024 *
-
P/E 2025 -0.07x
Enterprise Value -465K -409K -381K -350K -657K -44.62M -665K -4.53M -1.77M -22.03M -1.75M -1.71M -76.16M EV / Sales 2024
-0.06x
EV / Sales 2025 0.26x
Free-Float
99.99%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 64 29/06/2026
Director of Finance/CFO 48 01/02/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 76 02/08/2011
Chairman 77 30/09/2012
Director/Board Member 63 31/10/2023
Change 5-day change 1-year change 3-year change Capi.($)
-0.49%-0.73% - - 292K
+2.60%+9.95%+18.68%+2.43% 208B
+1.43%+11.99%-1.22%-22.92% 138B
+2.40%+4.97%-25.61%+12.53% 126B
+2.80%+8.80%-55.60%-9.09% 67.64B
+0.45%-0.39%+7.30%+0.57% 47.81B
+1.46%+4.46%-24.69%-31.49% 45.03B
+0.98%+5.41%+17.16%+11.11% 38.94B
+1.21%+2.46%+24.55%+31.78% 36.45B
+2.56%+6.80%-23.54%-6.30% 29.29B
Average +1.57%+1.03%-7.00%-1.26% 81.92B
Weighted average by Cap. +2.03%+1.40%-4.29%-2.28%

Financials

2024 2025
Net sales 8.74M 7.68M 7.15M 6.57M 12.33M 838M 12.5M 85.01M 33.2M 414M 32.81M 32.1M 1.43B 8.27M 7.27M 6.77M 6.22M 11.67M 793M 11.82M 80.44M 31.42M 392M 31.04M 30.38M 1.35B
Net income -11.16M -9.82M -9.14M -8.39M -15.76M -1.07B -15.96M -109M -42.42M -529M -41.91M -41.01M -1.83B -17.52M -15.4M -14.34M -13.17M -24.73M -1.68B -25.05M -170M -66.56M -830M -65.77M -64.35M -2.87B
Net Debt -4.55M -4M -3.72M -3.42M -6.42M -436M -6.51M -44.26M -17.29M -215M -17.08M -16.71M -745M -757K -665K -619K -569K -1.07M -72.6M -1.08M -7.36M -2.88M -35.85M -2.84M -2.78M -124M
Logo CHF Solutions
Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Employees
-